FDA Inspection
Louisville Reproductive CenterLouisville Reproductive Center – FDA Inspection, Apr 8, 2021
Record Details
This FDA Inspection record concerns Louisville Reproductive Center, with an inspection on April 8, 2021, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- April 8, 2021
- Product Type
- Biologics
View Company Profile
ID · be4e0020-85d0-4a7c-9d95-c5c1e7d28a6a
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1139891
- FDA center
- Biologics
- Project area
- Vaccines and Allergenic Products
Other FDA inspections of Louisville Reproductive Center
8| Date | Classification | Office | Project area |
|---|---|---|---|
| April 28, 2025 | OAI | Cincinnati District Office | Human Cellular, Tissue, and Gene Therapies |
| August 22, 2023 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 14, 2022 | NAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| January 4, 2018 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| June 15, 2017 | OAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Louisville Reproductive Center
- FDA Inspection 1268429 - 2025-04-28
- FDA Inspection 1215469 - 2023-08-22
- FDA Inspection 1172027 - 2022-06-14
- FDA Inspection 1037302 - 2018-01-04
- FDA Inspection 1014448 - 2017-06-15
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.